July 23, 2019
General Information | |
Duration | 1 semester (14 teaching weeks) |
Level | Year 4, Semester 8 |
Unit Weighting | Unit Credit Points: 10 credit points Total Course Credit Points: 320 credit points |
Student Workload | Number of timetabled hours per week: 4 Number of personal study hours per week: 6 Total workload hours per week: 10 |
Prerequisites | CHM208 Chinese Herbal Medicine & Formulae 3 |
Academic Details | |
Description | This unit aims to enable students to apply their knowledge and clinical skills in the management of common contemporary medical conditions with Chinese herbal medicine. The unit consolidates for students their developing clinical application of Chinese herbal medicine for diseases diagnosed through Western medicine. The unit covers relevant terminology, clinical manifestations, definition, aetiologies, pathologies of the diseases, and diagnostic methods in Western medicine and Chinese medicine, the strengths and limitations of herbal treatment, and the necessary referral. The emphasis will be on the clinical application of Chinese herbal medicine for the diseases of the respiratory system, cardiovascular system, hepatic system, digestive system, renal system and nervous system. The application and management of cancer, diabetes, autoimmune diseases, stroke and cerebral accidents with Chinese herbal medicine will also discussed. Students will be informed about restricted and scheduled herbs and their use throughout the study of this subject in accordance with Australian regulations and the SUSMP. Emphasis will be placed on awareness of cultural and social issues/concerns within the Australian healthcare context, the importance of a commitment to appropriate reporting of adverse events, and the implementation of appropriate first aid measures when a patient displays an adverse reaction to treatment, and ensure prompt transfer to medical services where necessary and/or appropriate. The desire to achieve excellence in the practice of Chinese herbal medicine and to contribute to improving both the quality of life of patients and the wellbeing of the community and the environment will be a key feature in the teaching and learning of this unit. |
Learning outcomes |
|
Unit requirement | To successfully complete the unit, students must: attend 80% of all the lectures and tutorial classes; attempt all assessment tasks and achieve at least 50% of the total marks, and achieve a mark of at least 40% in the final examination. |
Assessment | Assessment 1: Short Answer questions (20%)
Assessment 2: Case Study Analysis (30%) Assessment 3: Final Examination (50%) |
Prescribed text | * The prescribed and recommended readings are subject to annual review.
N/A |
Recommended readings | Fan, F. F., Xu, Q., Sun, Q., Zhao, S. J., Wang, P., & Guo, X. R. (2014). Assessment of the reporting quality of randomized controlled trials on treatment of coronary heart disease with traditional Chinese medicine from the Chinese journal of integrated traditional and Western medicine: A systematic review. Plos ONE, 9(1): e86360. doi:10.1371/journal.pone.0086360
Flaws B, Sionneau P (2001). The Treatment of Modern Western Medical Diseases with CHINESE Medicine, A Textbook and Clinical Manual. Boulder: Blue Poppy Press, 2001 He, L. Q., Shen, P. C., Fu, Q., Li, J., Dan, M., Wang, X. Y., Jia, W. (2009). Nephro-protective effect of Kangqianling decoction on chronic renal failure rats. Journal of Ethnopharmacology, 122(2), 367-373. doi: 10.1016/j.jep.2008.12.018 Hou, W. et al. (2011). Treating Autoimmune disease with Chinese Medicine. London: Churchill Livingstone. Li, Y., Li, J. S., Li, W. W., Li, S. Y., Tian, Y. G., Lu, X. F., … Wang, Y. (2014). Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-Kb/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complementary and Alternative Medicine, 14:140. doi: 10.1186/1472-6882-14-140 Wang, H., Mu, W., Zhai, J. B., Xing, D. M., Miao, S. J., Wang, J.,…Shang, H. C. (2013). The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: Study protocol for a randomized double-blind and placebo-controlled clinical trial. Trials, 14(1), 1-8. doi: 10.1186/1745-6215-14-165 Yu, R. C. (2012). Cancer Management with Chinese Medicine, World Scientific Publishing Zhang, Y. Q., Liu, Y. M., Zhang, Y., … Yang, X. C. (2013). Chinese herbal medicine Qi Ju Di Huang Wang for the treatment of essential hypertension: A systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine, article ID 262685, 10 pages. doi: 10.1155/2013/262685 |